Net Income (Loss) Attributable to Parent in USD of Quantumzyme Corp. from Q3 2015 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Quantumzyme Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2015 to Q2 2025.
  • Quantumzyme Corp. Net Income (Loss) Attributable to Parent for the quarter ending July 31, 2025 was -$38.2K, a 7.4% increase year-over-year.
  • Quantumzyme Corp. Net Income (Loss) Attributable to Parent for the twelve months ending July 31, 2025 was -$199K, a 11.6% decline year-over-year.
  • Quantumzyme Corp. annual Net Income (Loss) Attributable to Parent for 2025 was -$199K, a 11.6% decline from 2024.
  • Quantumzyme Corp. annual Net Income (Loss) Attributable to Parent for 2024 was -$179K.
  • Quantumzyme Corp. annual Net Income (Loss) Attributable to Parent for 2018 was -$28.2K, a 14.3% increase from 2017.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Quantumzyme Corp. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$199K -$38.2K +$3.05K +7.4% May 1, 2025 Jul 31, 2025 10-K/A 2025-11-17
Q1 2025 -$202K -$65.8K -$1.9K -2.98% Feb 1, 2025 Apr 30, 2025 10-Q 2025-06-20
Q4 2024 -$200K -$29.8K -$23.8K -398% Nov 1, 2024 Jan 31, 2025 10-Q 2025-06-20
Q3 2024 -$177K -$65.5K +$1.98K +2.93% Aug 1, 2024 Oct 31, 2024 10-Q 2025-06-20
Q2 2024 -$179K -$41.2K May 1, 2024 Jul 31, 2024 10-K/A 2025-11-17
Q1 2024 -$63.9K Feb 1, 2024 Apr 30, 2024 10-Q 2025-06-20
Q4 2023 -$5.98K Nov 1, 2023 Jan 31, 2024 10-Q 2025-06-20
Q3 2023 -$67.5K Aug 1, 2023 Oct 31, 2023 10-Q 2025-06-20
Q2 2018 -$28.2K -$26.4K -$26.9K -5765% May 1, 2018 Jul 31, 2018 10-K 2018-11-20
Q1 2018 -$1.3K $162 -$9.81K -98.4% Feb 1, 2018 Apr 30, 2018 10-Q 2018-05-08
Q4 2017 $8.5K $162 +$15.1K Nov 1, 2017 Jan 31, 2018 10-Q 2018-05-08
Q3 2017 -$6.55K -$2.09K +$26.3K +92.6% Aug 1, 2017 Oct 31, 2017 10-Q 2017-12-18
Q2 2017 -$32.9K $466 +$779 May 1, 2017 Jul 31, 2017 10-K 2018-11-20
Q1 2017 -$33.6K $9.97K +$10K Feb 1, 2017 Apr 30, 2017 10-Q 2018-05-08
Q4 2016 -$43.7K -$14.9K -$13.4K -874% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-13
Q3 2016 -$30.3K -$28.4K -$26.5K -1432% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-18
Q2 2016 -$3.74K -$313 May 1, 2016 Jul 31, 2016 10-K 2017-09-19
Q1 2016 -$47 Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-13
Q4 2015 -$1.53K Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-20
Q3 2015 -$1.85K Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-12

Quantumzyme Corp. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 -$199K -$20.7K -11.6% Aug 1, 2024 Jul 31, 2025 10-K/A 2025-11-17
2024 -$179K Aug 1, 2023 Jul 31, 2024 10-K/A 2025-11-17
2018 -$28.2K +$4.69K +14.3% Aug 1, 2017 Jul 31, 2018 10-K 2018-11-20
2017 -$32.9K -$29.1K -778% Aug 1, 2016 Jul 31, 2017 10-K 2018-11-20
2016 -$3.74K Aug 1, 2015 Jul 31, 2016 10-K 2017-09-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.